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16S DNA polymerase chain reaction (PCR) is a molecular amplifica-
tion technique that can be used to identify bacterial pathogens in 
culture-negative endocarditis. Bacterial DNA can be isolated from 
surgically excised valve tissue or from blood collected in EDTA vials. 
Use of this technique is particularly helpful in identifying the bacterial 
pathogen in cases of culture-negative endocarditis. A case involving a 
48-year-old man who presented with severe aortic regurgitation and a 
four-month prodrome of low-grade fever is reported. Blood and valve 
tissue cultures following valve replacement were negative. A valve 
tissue sample was sent for investigation with 16S DNA PCR, which 
successfully identified Streptococcus salivarius and was interpreted as 
the true diagnosis. A review of the literature suggests that 16S DNA 
PCR from valve tissue is a more sensitive diagnostic test than culture. 
It is also extremely specific, based on a sequence match of at least 
500 base pairs. 
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Une endocardite à culture négative diagnostiquée 
au moyen de la réaction en chaîne de la polymérase 
ADN 16S
La réaction en chaîne de la polymérase (PRN) ADN 16S est une technique 
d’amplification moléculaire qui peut être utilisée pour déterminer les 
pathogènes bactériens en cas d’endocardite à culture négative. L’ADN 
bactérien peut être isolé des tissus valvulaires excisés par voie chirurgicale 
ou du sang recueilli dans des fioles d’EDTA. Cette technique est 
particulièrement utile pour déterminer le pathogène bactérien dans les cas 
d’endocardite à culture négative. Les auteurs présentent le cas d’un homme 
de 48 ans qui a consulté à cause d’une régurgitation aortique importante 
et d’un prodrome de faible fièvre depuis quatre mois. Les cultures du sang 
et des tissus valvulaires effectuées après le remplacement valvulaire se 
sont révélées négatives. Un échantillon de tissu valvulaire a été soumis 
à une PCR ADN 16S, laquelle a déterminé la présence de Streptococcus 
salivarius, interprété comme le véritable diagnostic. D’après une analyse 
bibliographique, la PCR ADN 16S prélevée dans le tissu valvulaire 
serait un test diagnostique plus sensible que la culture. Elle est également 
d’une extrême spécificité, grâce à un appariement séquentiel d’au moins 
500 paires de base.
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CASe PreSeNtAtIoN
A 48-year-old man presented to a peripheral hospital in November 2010 with a one-month history of chest tightness and shortness 
of breath. The shortness of breath was present at rest and worsened 
with activity. He also reported a four-month history of fatigue and 
intermittent low-grade fever. The patient described a period of respira-
tory illness with flu-like symptoms shortly after skinning rabbits, six 
months before the start of his symptoms. 
His medical history was significant for gastroesophageal reflux dis-
ease as well as an excised stage I melanoma. There was no previous 
history of ischemic heart disease, left ventricular dysfunction or val-
vular abnormalities. There was no history of smoking, alcohol use or 
intravenous drug use. 
Physical examination demonstrated normal vital signs and normal 
jugular venous pressure. He was afebrile. There was a positive ‘water-
hammer’ carotid pulse noted. There was also a loud III/VI diastolic 
murmur heard along the right sternal border with radiation to the 
carotid arteries bilaterally. On respiratory examination, there were a 
few bilateral inspiratory wheezes. The remainder of the physical exam-
ination was unremarkable.
 Transthoracic echocardiogram revealed ‘dilated left heart cham-
bers’ with ‘preserved left ventricular systolic and diastolic function’ 
and ‘severe aortic regurgitation’. The patient was transferred to the 
cardiac surgery service for evaluation.
An initial complete blood count showed a white blood count 
of 10.4×109/L, hemoglobin level of 158 g/L and platelet count of 
205×109/L. Electrolytes, urea and creatinine levels were normal. 
An electrocardiogram revealed a Mobitz type II second-degree 
atrioventricular block. Chest x-ray showed an enlarged cardiac sil-
houette with clear lung fields. Repeat echocardiogram revealed ‘severe 
aortic insufficiency through a perforated inferior cusp’, with a mark-
edly dilated left ventricle with normal function. There was a large 
regurgitant orifice measuring 6 mm in diameter through the inferior 
cusp, and the edges of the cusp were fibrotic with small mobile strands 
seen. Cardiac catheterization revealed ‘severe aortic insufficiency [and 
an] enlarged left ventricle with well preserved systolic function’ and 
normal coronary artery anatomy.
The patient was started on empirical treatment for bacterial endo-
carditis with intravenous vancomycin 1 g every 12 h and intravenous 
gentamicin 90 mg every 8 h. A temporary pacemaker was placed. Blood 
cultures sent on admission to hospital before antibiotic administration 
did not yield any growth at 21 days. A urine sample sent for Legionella 
pneumophilia serogroup 1 antigen testing was negative. Serological test-
ing for Coxiella burnetti and Brucella species was negative. The anti-
Bartonella titre was 1:128, with a convalescent anti-Bartonella titre 
obtained three months later showing a decreased titre of 1:64. 
Six blood cultures drawn during febrile periods in hospital did 
not yield any growth. Two were drawn the day of admission to hos-
pital, and the other four were drawn during the first week, just before 
surgery. All cultures were drawn from peripheral sites. Intravenous 
ciprofloxacin 400 mg every 12 h was subsequently added to the vanco-
mycin and gentamicin regimen (1). The patient underwent an aortic 
valve replacement with a 25 mm mechanical valve (St Jude Medical, 
USA) on November 15, 2010. Pathological examination of the aortic 
valve tissue showed acute inflammation, fibrinoid necrosis, calcifica-
tions and fibrodegenerative changes. Gram-stain of the valve tissue 
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was negative. Three valve tissue samples were obtained, two for tissue 
culture via conventional microbiological methods, and a third sample 
was sent to the molecular laboratory at the Queen Elizabeth II Health 
Sciences Centre in Halifax, Nova Scotia. 
16S DNA polymerase chain reaction (PCR) was performed on the 
tissue sample. Primers from a commercially available kit were used 
along with the BLAST online database to determine that DNA from 
Streptococcus salivarius was present in the tissue. The patient was dis-
charged from hospital with an uncomplicated postoperative course, 
and was prescribed intravenous therapy with ceftriaxone and genta-
micin. The patient had one re-admission to hospital one month fol-
lowing discharge for symptomatic bradycardia and was discharged after 
pacemaker rate adjustment. One year after discharge, he was able to 
perform strenuous work and has normal prosthetic valve and pace-
maker function.
DISCUSSIoN
Culture-negative endocarditis may cause up to 31% of all cases of 
infective endocarditis (IE) (2). Our patient had clear echocardio-
graphical evidence of new regurgitation and a history of fever on 
presentation, but both his blood and tissue cultures were negative. 
This would satisfy one major and one minor criterion for a diagnosis of 
possible IE by the modified Duke criteria (1,3). In this setting, empir-
ical antibiotic treatment is appropriate to cover all likely organisms, 
but the identification of a specific organism is preferred for appropriate 
medical and surgical management.  
It is difficult to achieve a diagnosis of definite IE using the modified 
Duke criteria if all cultures are negative, although it can be achieved 
with minor criteria. Molecular diagnostic tests applied to excised tissue 
have not been included in the Duke criteria to date (1). 
Our patient had an interesting history of skinning rabbits, sug-
gesting a diagnosis of Francisella tularensis. Tularemia is not commonly 
associated with endocarditis, rather, it manifests with adenopathy, 
pharyngitis or pneumonia.  If it were the correct diagnosis, bacterial 
DNA from Francisella would have been detected by 16S PCR.  
Serology for Bartonella species was positive; however, because the 
titre was declining over time, and because Bartonella endocarditis is 
generally associated with a very high titre (greater than 1:800) (4,5), 
this was interpreted as a past exposure and not an acute infection, 
according to guidelines from the National Microbiology Laboratory 
(Winnipeg, Manitoba) where the test was performed. 
The identification of S salivarius DNA from the valve tissue was 
considered the true diagnosis based on the propensity of this organism to 
cause IE, the lack of evidence for the diagnosis of other causes of culture-
negative endocarditis and the lack of history of previous endocarditis. 
The 16S DNA gene contains six conserved sequences that all bac-
teria have in common, as well as variable regions unique to certain 
bacterial species (6). PCR is used to amplify this variable region and 
the amplicon was sequenced and matched to an Internet database of 
16S sequences. This technique can be applied to peripheral blood or 
valve tissue, and it can be performed in one day.  
A recent, large prospective case series involving 819 suspected 
cases of blood culture-negative endocarditis demonstrated that the best 
histological, serological and molecular testing available was still only 
able to identify a causative microorganism in 62.7% of cases (2). 16S 
PCR was performed on 227 valve tissue samples and was positive in 
150 (sensitivity 66%). PCR was able to make a diagnosis in 109 cases 
in which serological tests were not diagnostic. Of these 109 cases, 
106 were tested with PCR from valve tissue and only three were 
tested with  PCR from peripheral blood, demonstrating that PCR from 
peripheral blood only rarely contributes additional diagnostic informa-
tion. Because broad-range PCR provides a bacterial DNA sequence 
of 500 base pairs or longer, a perfect match at all 500 positions with a 
sequence from a database provides outstanding specificity.
A recent, retrospective case series involving 269 valve tissues 
removed from 241 patients with IE diagnosed using the Duke criteria 
amplified 16S DNA and 23S DNA targets (7). Among patients 
with proven IE, 16S PCR was positive in 149 of 185 tissue samples 
(80.5% sensitivity), with no positivity found among cases of healed IE, 
ambiguous IE or no IE (100% specificity). Valve tissue culture demon-
strated sensitivity of 33.4% and specificity of 96.6%. 
In a retrospective collection involving 52 tissue samples taken from 
resected heart valves from patients suspected of having IE based on 
clinical, microbiological and echocardiograhical criteria, sensitivity of 
PCR was 42% compared with 7.8% for valve tissue culture and 11.8% 
for tissue Gram-staining (8). Another study involving 74 heart valves 
used blood culture as a reference standard, which is clearly a biased 
standard for diagnosis of culture-negative endocarditis. PCR demon-
strated a sensitivity of 72% compared with valve tissue culture at 26% 
(9). Sensitivity of valve tissue culture was markedly reduced in patients 
who had received antibiotic therapy for five days or more before surgery. 
This is a significant limitation, because in most cases of IE, surgery 
would occur later than five days after the initiation of antibiotics.  
Because patients with IE often receive empirical antibiotics before 
blood culture collection, PCR, in addition to conventional diagnostic 
testing, may offer an advantage in cases requiring surgery because bac-
terial DNA may persist after viable organisms are lost. Streptococcus 
pneumoniae DNA may persist seven years beyond the initial episode of 
endocarditis (10). 
Moreover, 16S DNA PCR from tissue may detect species that are 
difficult to culture. These include Legionella species, Bartonella species, 
Chlamydia species, Tropheryma whippelii, C burnetii and Mycobacterium 
species. Timely identification of rare or fastidious microorganisms in 
the setting of acute infection is significantly more likely with the PCR 
technique.  In the Fournier series of 106 blood culture-negative valve 
tissues diagnosed by PCR, 30 detected C burnetii, 26 detected Bartonella 
species and 17 detected T whippelii (2).
Disadvantages of 16S DNA PCR with heart valve tissue include 
false negatives due to PCR inhibitors in the tissue and potential 
environmental contamination with nonpathogenic bacterial DNA. 
The test is expensive, and no susceptibility information is provided. 
The identification is as good as the quality of the database used to 
search the sequence. The best available DNA match in the database is 
often considered the true diagnosis even though the true diagnosis may 
not be present in the database. For this reason, a larger sequence data-
base containing only high-quality, peer-reviewed submissions will 
provide optimal specificity. Few reports have compared sequences 
searched with different databases (11). 
The present case joins a number of reported cases in which 
molecular techniques provided the only means of diagnosis for culture- 
negative endocarditis (12-14). When tissue is available, even after 
prolonged antibiotic therapy, broad-range PCR may provide diagnoses 
that are not possible with serological or conventional culture means. 
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